Genes reveal risk of recurrence of kidney cancer
Looking at a person's DNA using a technique called DNA [...]
FDA approves adjuvant pembrolizumab for intermediate-high risk kidney cancer
The Food and Drug administration (FDA) in the USA has [...]
Local and regional recurrences of localised kidney cancer after nephrectomy
In this study 15 years of data from a single [...]
Potential biomarker to predict risk of recurrence after nephrectomy for locally advanced kidney cancer
Currently, the search for a reliable biomarker to identify those [...]
Predictive factors for recurrence after complete metastasectomy in metastatic kidney cancer patients
In this retrospective study, published in Science Direct this month, [...]
Microwave ablation is feasible for early stage kidney cancer
A recent study published in the journal Urology has shown [...]
Comparing outcomes for microwave ablation versus surgery in early stage kidney cancer
A recent study, published in the journal Urology this month, [...]
Metastasectomy followed by targeted therapy does not improve survival
The following video interview with Dr Elizabeth Plimack from the [...]
Sorafenib versus observation following surgery for metastatic kidney cancer
A potential treatment for a selected group of patients with [...]
